News

Zacks Investment Research on MSN5h
DTIL Gets FDA's Fast Track Tag for Hepatitis B Gene Therapy, Stock Up
Shares of Precision BioSciences DTIL rallied 23.8% on Tuesday after the company’s announcement that the FDA has granted Fast ...
MPR1d
Potentially Curative Gene Editing Tx for Chronic HBV Gets Fast Track Status
The Food and Drug Administration (FDA) has granted Fast Track designation to PBGENE-HBV, an investigational gene editing therapy for adults with chronic hepatitis B.
dvm3605d
Researchers to investigate new hepatitis B-like virus and its impact on cats
Currently, there is no feline vaccine for the hepatitis B virus, and the hepatitis B vaccine for humans is highly toxic to ...